Technology | Ultrasound Imaging | June 06, 2019

Civco Launches Envision Ultrasound Viral Barriers

Probe covers and scanning pads reduce the risk of gel contamination and simplify workflow, enabling 100 percent gel-free procedures

Civco Launches Envision Ultrasound Viral Barriers

June 6, 2019 — Civco Medical Solutions announced a new solution that removes gel from ultrasound procedures. Envision viral barriers allow for 100 percent gel-free procedures.

Envision ultrasound probe covers and scanning pads are activated with a sterile liquid and require no gel. This reduces the risk of contamination, can improve the quality of fine needle aspiration (FNA) specimens and simplifies clinician workflow.

Ultrasound gel can pose a contamination risk in certain procedures, and multiple clinical studies have shown sterile ultrasound gel to be the cause of healthcare-associated infections. Studies report that gel can:

  • Contribute to increasing nosocomial infection, the spread of hospital acquired infections1,2,3,4
  • Cause bacteria to be introduced into the blood stream3,6
  • Make the disinfection of sterilization process of devices, including ultrasound probes, less effective5

Utilizing Envision during needle-guided interventions — including central venous catheter (CVC) and peripherally inserted central catheter (PICC) procedures, or while scanning non-intact skin — eliminates the need for gel and helps reduce the risk of contamination.

Gel is also commonly used during an ultrasound-guided fine needle aspiration (FNA) procedure. However, clinical studies have shown the adverse effects ultrasound gel can have on FNA specimens:

  • Impairs the visibility of cells and interferes with staining of cells7
  • Causes a significant increase in the number of slides with artifacts7
  • Causes widespread cell lysis, increasing the risk of misinterpretation and a false positive diagnosis8
  • Mimics colloid, creating difficulty in differentiation between artifact and colloid7,9

Envision covers can help improve the visibility of cells in FNAs by removing gel from these procedures.

Envision viral barriers are available in two configurations: an ultrasound probe cover and a scanning pad. Envision probe covers can be used during ultrasound-guided needle interventions, and the Envision pad adheres to the patient or the ultrasound probe to scan non-intact or sensitive areas, including on neonates or post-surgical wound sites.

The probe cover and scanning pad enable physicians and clinicians to simplify workflow throughout a procedure:

  • A quick-peel, silicone liner adheres safely to the probe face or to the patient's skin — no gel needed inside the cover or applied to the patient
  • Apply a sterile liquid, such as sterile saline, to the Envision cover or pad, or directly on the patient's skin, and begin scanning
  • Pre-cleaning of the ultrasound probe is simplified without gel, before sending to high-level disinfection

Envision is approved by the U.S. Food and Drug Administration (FDA) for use in the United States, and available for sale in numerous countries around the globe.

For more information: www.civco.com

References

  1. Oleszkowicz S.C., Chittick P., Russo V., et al. Infections Associated with Use of Ultrasound Transmission Gel: Proposed Guidelines to Minimize Risk Infection Control and Hospital Epidemiology Dec. 2012, vol. 33, no. 12
  2. Nannini E.C., Ponessa A., Muratori R., et al. Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel. The Brazilian Journal of Infectious Diseases 2015;19(5);543-545
  3. Shaban R.Z., Maloney S., Gerrard J., et al. Outbreak of health care-associated Burkholderia cenocepacia bacteremia and infection attributed to contaminated sterile gel used for central line insertion under ultrasound guidance and other procedures. AJIC 45 (2017) 954-8
  4. Centers for Disease Control and Prevention. Pseudomonas aeruginosa respiratory tract infections associated with contaminated ultrasound gel used for transesophageal echocardiography - Michigan, December 2011-January 2012. MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:262-4.
  5. Rutala W.A., Weber D.J., and the Healthcare Infection Control Practices Advisory Committee "CDC - Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008" https://www.cdc.gov/infectioncontrol/guidelines/disinfection/index.html  
  6. Australian Government Department of Health Therapeutic Goods Administration "Safety Advisory – risk of bacterial contamination" 2017 https://www.tga.gov.au/alert/meditech-ultrasound-gel  
  7. Lalzad A., Ristitsch D., Downey W., et al. Effect of ultrasound transmission gel on ultrasound-guided fine needle aspiration cytological specimens of thyroid. Cytopathology 2012, 23, 330–333
  8. Molyneux A.J., Coghill S.B. Cell Lysis Due to Ultrasound Gel In Fine Needle Aspirates; an Important New Artefact In Cytology Cytopathology 1994 5, 41-45
  9. Royer M.C., Davidson D.D., Dimitrov R.K., et al. Ultrasound gel causes fine needle aspiration artifact? A clear choice. Acta Cytol. 2012;56(2):146-54

Related Content

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Konica Minolta Healthcare Introduces New Financing Services Program for Exa Enterprise Imaging
News | Enterprise Imaging | June 17, 2019
June 17, 2019 – Konica Minolta Healthcare Americas Inc.
Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.
News | Digital Pathology | June 14, 2019
Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
M*Modal and Community Health Network Partner on AI-powered Clinical Documentation
News | PACS Accessories | June 13, 2019
M*Modal announced that the company and Community Health Network (CHNw) are collaborating to transform the patient-...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...